Extended Survival In IV Drug Users With AIDS

16 July 1997

A study comparing the progression of AIDS in 63 homosexual or bisexualmen against that in 125 intravenous drug users has noted that patients who acquired AIDS through abuse of IV drugs lived significantly longer than patients with sexually-acquired AIDS. The study was published in the July issue of AIDS.

Reuters reports that 10 years after infection, 54% of the homosexual men had developed an AIDS-related illness, while 51% had died of AIDS. In the group of iv drug users, the figures were 26% and 15%. However, the study authors says that there was no difference in overall mortality between the two groups, with an annual 4% non-HIV-related mortality in the drug user group.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight